Copernicus Therapeutics Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $6.7M

  • Investors
  • 1

Copernicus Therapeutics General Information

Description

Developer of biopharmaceutical precision medicine designed to utilize gene therapy to treat diseases. The company specializes in nanoparticle delivery systems to treat diseases without all of the drawbacks of Adeno-associated virus therapies to treat diseases by using a non-immunogenic, nanoparticle-based delivery system, enabling health professionals to deliver life-saving medicines and therapies to reduce the potential risk to patients with fewer hospital visits and optimized long-term gene expression.

Contact Information

Formerly Known As
Copernicus Gene Systems
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11000 Cedar Avenue
  • Suite 145
  • Cleveland, OH 44106
  • United States
+1 (216)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Corporate Office
  • 11000 Cedar Avenue
  • Suite 145
  • Cleveland, OH 44106
  • United States
+1 (216)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Copernicus Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Grant 31-Mar-2022 $6.7M Completed Clinical Trials - Phase 1
10. Secondary Transaction - Private 17-Apr-2015 Completed Clinical Trials - General
9. Later Stage VC 02-Sep-2008 Completed Clinical Trials - General
8. Later Stage VC 15-Feb-2007 Completed Clinical Trials - General
7. Grant 14-Feb-2006 Completed Clinical Trials - General
6. Later Stage VC 02-May-2005 Completed Clinical Trials - General
5. Grant 20-Jan-2005 Completed Clinical Trials - General
4. Later Stage VC 06-Jan-2003 Completed Clinical Trials - General
3. Later Stage VC 18-Nov-2002 $2.5M $5.5M Completed Startup
2. Grant 01-Jan-2001 $300K $3M Completed Startup
To view Copernicus Therapeutics’s complete valuation and funding history, request access »

Copernicus Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biopharmaceutical precision medicine designed to utilize gene therapy to treat diseases. The company specia
Drug Delivery
Cleveland, OH
7 As of 2026

Vienna, Austria
 

Birmingham, AL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Copernicus Therapeutics Competitors (6)

One of Copernicus Therapeutics’s 6 competitors is Pfizer (Vienna), a Corporation company based in Vienna, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer (Vienna) Corporation Vienna, Austria
Southern Research Institute Corporation Birmingham, AL
Immuto Scientific Venture Capital-Backed Cambridge, MA
Pfizer Pakistan Corporation Karachi, Pakistan
Analiza Venture Capital-Backed Cleveland, OH
To view Copernicus Therapeutics’s complete competitors history, request access »

Copernicus Therapeutics Patents

Copernicus Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3083743-A1 Gene therapy for ocular improvement Active 29-Nov-2017
CA-3083743-C Gene therapy for ocular improvement Active 29-Nov-2017
EP-3717024-A2 Gene therapy for ocular improvement Active 29-Nov-2017
EP-3717024-A4 Gene therapy for ocular improvement Active 29-Nov-2017
EP-3717024-B1 Gene therapy for ocular improvement Active 29-Nov-2017 A61K48/0075
To view Copernicus Therapeutics’s complete patent history, request access »

Copernicus Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Copernicus Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute on Drug Abuse (NIDA) Government
To view Copernicus Therapeutics’s complete investors history, request access »

Copernicus Therapeutics FAQs

  • When was Copernicus Therapeutics founded?

    Copernicus Therapeutics was founded in 1997.

  • Where is Copernicus Therapeutics headquartered?

    Copernicus Therapeutics is headquartered in Cleveland, OH.

  • What is the size of Copernicus Therapeutics?

    Copernicus Therapeutics has 7 total employees.

  • What industry is Copernicus Therapeutics in?

    Copernicus Therapeutics’s primary industry is Drug Delivery.

  • Is Copernicus Therapeutics a private or public company?

    Copernicus Therapeutics is a Private company.

  • What is Copernicus Therapeutics’s current revenue?

    The current revenue for Copernicus Therapeutics is .

  • How much funding has Copernicus Therapeutics raised over time?

    Copernicus Therapeutics has raised $15.8M.

  • Who are Copernicus Therapeutics’s investors?

    National Institute on Drug Abuse (NIDA) has invested in Copernicus Therapeutics.

  • Who are Copernicus Therapeutics’s competitors?

    Pfizer (Vienna), Southern Research Institute, Immuto Scientific, Pfizer Pakistan, and Analiza are some of the 6 competitors of Copernicus Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process